Active

ArchiMed

General contacts
Investor type

PE

Founded

2014

AUM

$9 000 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

Europe North America
Investor profile last updated: 23 November, 2025

Profile

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.

ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.

Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

Industry

Business Services (B2B) Healthcare Services Security Software Education Edtech Financial Services Fintech Food and Beverage Foodtech Transportation MedTech LegalTech HealthTech SaaS

ArchiMed Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
 MED I
Private Equity (PE)
Financial Services
Fintech
Healthcare Services
SaaS
Software
HealthTech
Series B
Late Stage (Series C+)
North America
Europe
$5-10 m
$155 M
December 2014

Contacts

Name
Title
Email
Social Networks
avatar
Christoph Bohmer Operating Partner
Operating Partner
c•••@•••
LinkedIn
avatar
Denis Ribon Co-Founder & Managing Partner
Co-Founder & Managing Partner
d•••@•••
LinkedIn
Upgrade to see contacts
avatar
ILFfDjoUlzm5E2va ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va@ILFfDjoUlzm5E2va.com
linkedin twitter
avatar
ILFfDjoUlzm5E2va ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va@ILFfDjoUlzm5E2va.com
linkedin twitter
avatar
ILFfDjoUlzm5E2va ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va
ILFfDjoUlzm5E2va@ILFfDjoUlzm5E2va.com
linkedin twitter
Investment-team contacts for ArchiMed — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about ArchiMed

ArchiMed is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
ArchiMed is located in New York, New York, United States.
ArchiMed was founded in 2014.
ArchiMed invests in companies and startups in Business Services (B2B), Healthcare Services, Security, Software, Education, Edtech, Financial Services, Fintech, Food and Beverage, Foodtech, Transportation, MedTech, LegalTech, HealthTech, SaaS.
ArchiMed invests in companies and startups in Europe, North America.
ArchiMed invests in companies and startups at Series B, Late Stage (Series C+).
ArchiMed usually invests $10-50 m on average.
ArchiMed has around $9 000m assets under management.
ArchiMed last fund was created/launched in 2014-12-10
ArchiMed can be reached through its website archimed.group and its LinkedIn page. Its general enquiries address is contact@archimed-group.eu. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for ArchiMed — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query ArchiMed directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 23 November, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.